Spark Investment Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-48,500
Closed -$619K 758
2018
Q4
$619K Sell
48,500
-27,700
-36% -$420K 0.04% 367
2018
Q3
$1.24M Sell
76,200
-67,900
-47% -$971K 0.07% 352
2018
Q2
$1.86M Buy
144,100
+44,800
+45% +$605K 0.11% 258
2018
Q1
$1.24M Buy
99,300
+61,100
+160% +$744K 0.08% 308
2017
Q4
$533K Sell
38,200
-46,930
-55% -$687K 0.03% 437
2017
Q3
$1.43M Sell
85,130
-65,370
-43% -$1.06M 0.08% 328
2017
Q2
$2.53M Hold
150,500
0.16% 206
2017
Q1
$2.33M Buy
150,500
+89,300
+146% +$1.28M 0.15% 223
2016
Q4
$914K Buy
61,200
+21,900
+56% +$307K 0.08% 354
2016
Q3
$493K Buy
39,300
+100
+0.3% +$1K 0.04% 486
2016
Q2
$352K Sell
39,200
-13,500
-26% -$132K 0.03% 523
2016
Q1
$522K Sell
52,700
-10,200
-16% -$105K 0.05% 422
2015
Q4
$723K Buy
62,900
+7,100
+13% +$87.9K 0.09% 297
2015
Q3
$751K Buy
+55,800
New +$756K 0.1% 300
2015
Q2
Sell
-20,000
Closed -$281K 776
2015
Q1
$281K Buy
+20,000
New +$272K 0.04% 481

Other funds holding OXFD

Spark Investment Management's OXFD Position: Q1 2019 in Review

Spark Investment Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2019, closing a stake of 48,500 shares — an estimated $619K sold.

Spark Investment Management first reported a position in OXFD in Q1 2015 and held it in 15 quarters. The position peaked at $2.53M in Q2 2017. 92 funds tracked by Wall St. Rank hold OXFD as of Q1 2019.

  • Spark Investment Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2019 after selling out during the quarter.
  • Spark Investment Management sold 48,500 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2019, an estimated $619K.
  • Spark Investment Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2015 and held it in 15 quarters.
  • Spark Investment Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $2.53M in Q2 2017.
  • 92 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2019.

Based on Spark Investment Management's 13F filing for Q1 2019, filed 7 May 2019.